Correlation Between Syndax Pharmaceuticals and Catalyst Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Syndax Pharmaceuticals and Catalyst Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Syndax Pharmaceuticals and Catalyst Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Syndax Pharmaceuticals and Catalyst Pharmaceuticals, you can compare the effects of market volatilities on Syndax Pharmaceuticals and Catalyst Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Syndax Pharmaceuticals with a short position of Catalyst Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Syndax Pharmaceuticals and Catalyst Pharmaceuticals.
Diversification Opportunities for Syndax Pharmaceuticals and Catalyst Pharmaceuticals
0.12 | Correlation Coefficient |
Average diversification
The 3 months correlation between Syndax and Catalyst is 0.12. Overlapping area represents the amount of risk that can be diversified away by holding Syndax Pharmaceuticals and Catalyst Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Catalyst Pharmaceuticals and Syndax Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Syndax Pharmaceuticals are associated (or correlated) with Catalyst Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Catalyst Pharmaceuticals has no effect on the direction of Syndax Pharmaceuticals i.e., Syndax Pharmaceuticals and Catalyst Pharmaceuticals go up and down completely randomly.
Pair Corralation between Syndax Pharmaceuticals and Catalyst Pharmaceuticals
Given the investment horizon of 90 days Syndax Pharmaceuticals is expected to generate 1.86 times less return on investment than Catalyst Pharmaceuticals. But when comparing it to its historical volatility, Syndax Pharmaceuticals is 1.0 times less risky than Catalyst Pharmaceuticals. It trades about 0.06 of its potential returns per unit of risk. Catalyst Pharmaceuticals is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest 2,107 in Catalyst Pharmaceuticals on December 28, 2024 and sell it today you would earn a total of 408.00 from holding Catalyst Pharmaceuticals or generate 19.36% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Syndax Pharmaceuticals vs. Catalyst Pharmaceuticals
Performance |
Timeline |
Syndax Pharmaceuticals |
Catalyst Pharmaceuticals |
Syndax Pharmaceuticals and Catalyst Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Syndax Pharmaceuticals and Catalyst Pharmaceuticals
The main advantage of trading using opposite Syndax Pharmaceuticals and Catalyst Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Syndax Pharmaceuticals position performs unexpectedly, Catalyst Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Catalyst Pharmaceuticals will offset losses from the drop in Catalyst Pharmaceuticals' long position.Syndax Pharmaceuticals vs. Cogent Biosciences | Syndax Pharmaceuticals vs. Cullinan Oncology LLC | Syndax Pharmaceuticals vs. Kalvista Pharmaceuticals | Syndax Pharmaceuticals vs. Mersana Therapeutics |
Catalyst Pharmaceuticals vs. Day One Biopharmaceuticals | Catalyst Pharmaceuticals vs. Terns Pharmaceuticals | Catalyst Pharmaceuticals vs. X4 Pharmaceuticals | Catalyst Pharmaceuticals vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Complementary Tools
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |